Xenetic Biosciences (XBIO) Reports Q2 Loss of $0.34/Share

Xenetic Biosciences (NASDAQ: XBIO) reported Q2 EPS of ($0.34), versus ($6.12) reported last year.

For earnings history and earnings-related data on Xenetic Biosciences (XBIO) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand
• Amylyx ALS drug shows no serious adverse events in Phase 1 trial